Asthma — Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ?
Citation(s)
American Thoracic Society; European Respiratory Society ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30.
Bratton DL, Lanz MJ, Miyazawa N, White CW, Silkoff PE Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr Pulmonol. 1999 Dec;28(6):402-7.
Di Rosa M, Radomski M, Carnuccio R, Moncada S Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun. 1990 Nov 15;172(3):1246-52.
Gratziou C, Lignos M, Dassiou M, Roussos C Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J. 1999 Oct;14(4):897-901.
Harris JR, Magnus P, Samuelsen SO, Tambs K No evidence for effects of family environment on asthma. A retrospective study of Norwegian twins. Am J Respir Crit Care Med. 1997 Jul;156(1):43-9.
Hollá LI, Schüller M, Bucková D, Vácha J Neuronal nitric oxide synthase gene polymorphism and IgE-mediated allergy in the Central European population. Allergy. 2004 May;59(5):548-52.
Lee YC, Cheon KT, Lee HB, Kim W, Rhee YK, Kim DS Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy. 2000 Oct;55(10):959-63.
Lindberg S, Cervin A, Runer T Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol. 1997 Sep;117(5):728-34.
Ownby DR, Johnson CC, Peterson EL Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA. 2002 Aug 28;288(8):963-72.
Pohunek P, Warner JO, Turzíková J, Kudrmann J, Roche WR Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol. 2005 Feb;16(1):43-51.
Strachan DP Hay fever, hygiene, and household size. BMJ. 1989 Nov 18;299(6710):1259-60.
Tabachnik E, Levison H Postgraduate course presentation. Infantile bronchial asthma. J Allergy Clin Immunol. 1981 May;67(5):339-47. Review.
Thomas NS, Wilkinson J, Holgate ST The candidate region approach to the genetics of asthma and allergy. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 2):S144-51.
von Mutius E Environmental factors influencing the development and progression of pediatric asthma. J Allergy Clin Immunol. 2002 Jun;109(6 Suppl):S525-32. Review.
Wildhaber JH, Hall GL, Stick SM Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants. Am J Respir Crit Care Med. 1999 Jan;159(1):74-8.
Xu W, Liu L, Emson PC, Harrington CR, Charles IG Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene. 1997 Dec 19;204(1-2):165-70.
Yang H, Wei W, Menconi M, Hasselgren PO Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R337-4. Epub 2006 Sep 14.
Young S, Le Souëf PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med. 1991 Apr 25;324(17):1168-73. Erratum in: N Engl J Med 1991 Sep 5;325(10):747.
Zeiger RS, Dawson C, Weiss S Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):376-87.
Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.